Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Reticuline

Copy Product Info
😃Good
Catalog No. T4243Cas No. 485-19-8

Reticuline is an anti-inflammatory and antihypertensive natural product that reduces JAK2/STAT3 and NF-κB phosphorylation levels, inhibits TNF-α and IL-6 mRNA expression, thereby alleviating oedema in rats.

Reticuline

Reticuline

Copy Product Info
😃Good
Catalog No. T4243Cas No. 485-19-8
Reticuline is an anti-inflammatory and antihypertensive natural product that reduces JAK2/STAT3 and NF-κB phosphorylation levels, inhibits TNF-α and IL-6 mRNA expression, thereby alleviating oedema in rats.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mgInquiryInquiryInquiry
5 mg$1,390InquiryInquiry
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.However, due to objective factors, there is a small probability that the synthesis may not be successful during the R&D process. We appreciate your understanding.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Reticuline is an anti-inflammatory and antihypertensive natural product that reduces JAK2/STAT3 and NF-κB phosphorylation levels, inhibits TNF-α and IL-6 mRNA expression, thereby alleviating oedema in rats.
In vitro
In intact endothelium aortic rings, reticuline (3 μM-1.5 mM) concentration-dependently inhibited phenylephrine- and KCl (80 mM and 30 mM)-induced contractions, with IC50 values of 40±10, 240±40, and 300±40 μM, respectively [2].
After endothelium removal, the inhibitory effect of reticuline on phenylephrine-induced contraction was significantly attenuated, with an IC50 value of 250±70 μM [2].
In the presence of L-NAME (100 or 300 μM) or atropine (1 μM), the vasorelaxant effect of reticuline was also markedly reduced [2].
Reticuline further suppressed CaCl2-induced contraction and calcium transients triggered by the release of intracellular calcium stores sensitive to depolarizing agents such as phenylephrine, but did not affect caffeine-sensitive calcium stores [2].
In vivo
Reticuline (5, 10, and 20 mg/kg, intravenous injection) induced significant hypotensive responses in normotensive Wistar rats, accompanied by increased heart rate. After pretreatment with L-NAME or atropine, the hypotensive effect and tachycardia caused by reticuline were markedly attenuated or even completely abolished [2].
Chemical Properties
Molecular Weight329.39
FormulaC19H23NO4
Cas No.485-19-8
SmilesC([C@H]1C=2C(=CC(OC)=C(O)C2)CCN1C)C3=CC(O)=C(OC)C=C3
Relative Density.1.217g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (242.87 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (10.02 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.0359 mL15.1796 mL30.3591 mL151.7957 mL
5 mM0.6072 mL3.0359 mL6.0718 mL30.3591 mL
10 mM0.3036 mL1.5180 mL3.0359 mL15.1796 mL
20 mM0.1518 mL0.7590 mL1.5180 mL7.5898 mL
50 mM0.0607 mL0.3036 mL0.6072 mL3.0359 mL
100 mM0.0304 mL0.1518 mL0.3036 mL1.5180 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Reticuline | purchase Reticuline | Reticuline cost | order Reticuline | Reticuline chemical structure | Reticuline in vivo | Reticuline in vitro | Reticuline formula | Reticuline molecular weight